StockData
GeoVax Labs, Inc. logo

GeoVax Labs, Inc. (GOVX) stock

GOVXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$2.01−0.01 (-0.50%)

Close on Nov 17, 2026Market cap $14.81MP/E –Yield –

GeoVax Labs cash

Cash and short-term investments held at the end of each period.

GeoVax Labs's cash was $3.14M at Jun 30, 2026. For fiscal 2025 it was $3.09M, down 44.0% from the year before. Over ten years it grew 11.3% a year on average. The highest annual figure on record is $27.61M in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.09M-44.0%
FY2024Dec 31, 2024$5.51M-14.7%
FY2023Dec 31, 2023$6.45M-76.6%
FY2022Dec 31, 2022$27.61M+141.7%
FY2021Dec 31, 2021$11.42M+15.6%
FY2020Dec 31, 2020$9.88M+3388.3%
FY2019Dec 31, 2019$283.34K+9.1%
FY2018Dec 31, 2018$259.70K-17.0%
FY2017Dec 31, 2017$312.73K-31.1%
FY2016Dec 31, 2016$454.03K-57.2%
FY2015Dec 31, 2015$1.06M-3.7%
FY2014Dec 31, 2014$1.10M-56.2%
FY2013Dec 31, 2013$2.51M+142.7%
FY2012Dec 31, 2012$1.04M-11.3%
FY2011Dec 31, 2011$1.17M+8.2%
FY2010Dec 31, 2010$1.08M-69.3%
FY2009Dec 31, 2009$3.52M+60.5%
FY2008Dec 31, 2008$2.19M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.14M+1.6%
Q1 FY2026Mar 31, 2026$1.27M-82.9%
Q4 FY2025Dec 31, 2025$3.09M-44.0%
Q3 FY2025Sep 30, 2025$5.01M-41.7%
Q2 FY2025Jun 30, 2025$3.09M+98.1%
Q1 FY2025Mar 31, 2025$7.44M+867.5%
Q4 FY2024Dec 31, 2024$5.51M-14.7%
Q3 FY2024Sep 30, 2024$8.59M-32.3%
Q2 FY2024Jun 30, 2024$1.56M-91.2%
Q1 FY2024Mar 31, 2024$768.86K-96.8%
Q4 FY2023Dec 31, 2023$6.45M-76.6%
Q3 FY2023Sep 30, 2023$12.69M-63.4%
Q2 FY2023Jun 30, 2023$17.79M-42.4%
Q1 FY2023Mar 31, 2023$23.85M+46.7%
Q4 FY2022Dec 31, 2022$27.61M+141.7%
Q3 FY2022Sep 30, 2022$34.68M+91.5%
Q2 FY2022Jun 30, 2022$30.90M+58.2%
Q1 FY2022Mar 31, 2022$16.26M-22.0%
Q4 FY2021Dec 31, 2021$11.42M+15.6%
Q3 FY2021Sep 30, 2021$18.11M+56.4%
Q2 FY2021Jun 30, 2021$19.54M+2649.3%
Q1 FY2021Mar 31, 2021$20.84M+9296.8%
Q4 FY2020Dec 31, 2020$9.88M+3388.3%
Q3 FY2020Sep 30, 2020$11.58M+1934.0%
Q2 FY2020Jun 30, 2020$710.68K+228.4%
Q1 FY2020Mar 31, 2020$221.81K+26.0%
Q4 FY2019Dec 31, 2019$283.34K+9.1%
Q3 FY2019Sep 30, 2019$569.36K+11.4%
Q2 FY2019Jun 30, 2019$216.41K+13.3%
Q1 FY2019Mar 31, 2019$175.99K-69.2%
Q4 FY2018Dec 31, 2018$259.70K-17.0%
Q3 FY2018Sep 30, 2018$511.24K+48.7%
Q2 FY2018Jun 30, 2018$190.97K-76.8%
Q1 FY2018Mar 31, 2018$571.15K+242.5%
Q4 FY2017Dec 31, 2017$312.73K-31.1%
Q3 FY2017Sep 30, 2017$343.83K-32.7%
Q2 FY2017Jun 30, 2017$822.60K–
Q1 FY2017Mar 31, 2017$166.75K–
Q4 FY2016Dec 31, 2016$454.03K–
Q3 FY2016Sep 30, 2016$511.10K–

More GeoVax Labs figures

See a number that looks wrong?